menu
    • menu

    Company profile for Nanobiotix

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    "Nanobiotix has been pioneering nanomedicine for more than 17 years to bring a different approach to medicine.Our therapeutic technologies are not based on biology or chemistry – they are based on physical principles at nanoscale. This paradigm shift has allowed us to discover novel approaches to improving treatment outcomes.Our company designs and manufactures nanoparticles that safely enhance the efficacy of radiation ther...
    "Nanobiotix has been pioneering nanomedicine for more than 17 years to bring a different approach to medicine.Our therapeutic technologies are not based on biology or chemistry – they are based on physical principles at nanoscale. This paradigm shift has allowed us to discover novel approaches to improving treatment outcomes.Our company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. With this approach, our ambition is to benefit millions of patients who receive radiation therapy by improving the efficiency of radiation in tumor cells without increasing the dose.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NanobiotixFrance Flag
    Country
    Country
    France
    Address
    Address
    60, rue de Wattignies Bat C PARIS
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nanobiotix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nanobiotix?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A1749543%2Cidx%3A3-1-3%2CtarId%3A1463671034393%2Ctas%3Ananobiotix
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Nanobiotix

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Voting Rights and Shares Capital of the Company
    Voting Rights and Shares Capital of the Company

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255135/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    NANOBIOTIX To Participate In Investor Conferences In March
    NANOBIOTIX To Participate In Investor Conferences In March

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3245044/0/en/NANOBIOTIX-to-Participate-in-Investor-Conferences-in-March.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Voting Rights and Company Share Capital
    Voting Rights and Company Share Capital

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3218261/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    NANOBIOTIX Enters CAC Mid 60 And SBF 120 Indices On Euronext
    NANOBIOTIX Enters CAC Mid 60 And SBF 120 Indices On Euronext

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205143/0/en/NANOBIOTIX-to-Join-CAC-Mid-60-and-SBF-120-Indices-on-Euronext-Paris.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Nanobiotix Updates Q3 2025 Ops, Finances, and 2026 Plans
    Nanobiotix Updates Q3 2025 Ops, Finances, and 2026 Plans

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193940/0/en/Nanobiotix-Provides-Third-Quarter-2025-Operational-and-Financial-Update-Along-With-2026-Clinical-Outlook.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Nanobiotix Unveils Key Curadigm Nanoprimer Advances
    Nanobiotix Unveils Key Curadigm Nanoprimer Advances

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187870/0/en/NANOBIOTIX-Announces-Curadigm-Nanoprimer-Platform-Advancements-With-Updated-Plans-for-Internal-Pipeline-Development-and-External-Collaborations.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search